KalVista Pharmaceuticals (KALV) Assets Average: 2015-2024
Historic Assets Average for KalVista Pharmaceuticals (KALV) over the last 6 years, with Dec 2024 value amounting to $227.8 million.
- KalVista Pharmaceuticals' Assets Average was N/A to $227.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $227.8 million, marking a year-over-year change of. This contributed to the annual value of $105.3 million for FY2020, which is 17.35% up from last year.
- As of Q4 2024, KalVista Pharmaceuticals' Assets Average stood at $227.8 million, which was up 26.21% from $180.5 million recorded in Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Assets Average ranged from a high of $227.8 million in Q4 2024 and a low of $70.8 million during Q1 2021.
- Moreover, its 2-year median value for Assets Average was $174.7 million (2024), whereas its average is $170.0 million.
- In the last 5 years, KalVista Pharmaceuticals' Assets Average plummeted by 34.11% in 2021 and then soared by 92.29% in 2024.
- KalVista Pharmaceuticals' Assets Average (Quarterly) stood at $79.7 million in 2020, then slumped by 34.11% to $70.8 million in 2021, then reached $149.5 million in 2023, then climbed by 20.72% to $227.8 million in 2024.
- Its Assets Average stands at $227.8 million for Q4 2024, versus $180.5 million for Q4 2024 and $217.8 million for Q3 2024.